Multicenter phase II study of lurbinectedin in BRCAMutated and unselected metastatic advanced breast cancer and biomarker assessment substudy

  1. Cruz, C.
  2. Llop-Guevara, A.
  3. Garber, J.E.
  4. Arun, B.K.
  5. Perez Fidalgo, J.A.
  6. Lluch, A.
  7. Telli, M.L.
  8. Ferńandez, C.
  9. Kahatt, C.
  10. Galmarini, C.M.
  11. Soto-Matos, A.
  12. Alfaro, V.
  13. De La Haza, A.P.
  14. Domchek, S.M.
  15. Antolin, S.
  16. Vahdat, L.
  17. Tung, N.M.
  18. Lopez, R.
  19. Arribas, J.
  20. Vivancos, A.
  21. Baselga, J.
  22. Serra, V.
  23. Balmaña, J.
  24. Isakoff, S.J.
Revue:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Année de publication: 2018

Volumen: 36

Número: 31

Pages: 3134-3143

Type: Article

DOI: 10.1200/JCO.2018.78.6558 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus